Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition
- PMID: 1760713
- DOI: 10.1002/bjs.1800781142
Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition
Abstract
A prospective randomized study of the immunological effects of three total parenteral nutrition (TPN) regimens in patients undergoing preoperative parenteral nutrition was conducted. In one regimen the calories were derived solely from glucose. The others were identical except that 50 per cent of the calories were provided as lipid emulsion, in one as long-chain triglycerides (LCT) only while the other contained half the fat as medium-chain triglycerides (MCT) and half as LCT (MCT/LCT). Natural killer (NK) activity and lymphokine-activated killer (LAK) activity were significantly higher after TPN with the MCT/LCT solution. A significant fall in LAK activity occurred after TPN with the LCT solution. The interleukin 2 content in supernatants from activated T lymphocytes was significantly higher after TPN with the LCT-containing solution. Solutions containing LCT and those containing MCT perturb cytokine interactions, but this is less with MCT-containing solutions, which may augment certain responses. These observations may have implications for the design of TPN regimens.
Similar articles
-
Pharmacological concentrations of lipid emulsions inhibit interleukin-2-dependent lymphocyte responses in vitro.JPEN J Parenter Enteral Nutr. 1990 Jan-Feb;14(1):12-7. doi: 10.1177/014860719001400112. JPEN J Parenter Enteral Nutr. 1990. PMID: 2325241
-
MCT/LCT emulsion ameliorate liver fat deposition in insulin-treated diabetic rats receiving total parenteral nutrition.Clin Nutr. 1998 Dec;17(6):273-7. doi: 10.1016/s0261-5614(98)80319-1. Clin Nutr. 1998. PMID: 10205350
-
Effect of parenteral medium- and long-chain triglycerides on lymphocytes subpopulations and functions in patients with acquired immunodeficiency syndrome: a prospective study.JPEN J Parenter Enteral Nutr. 1998 Mar-Apr;22(2):67-71. doi: 10.1177/014860719802200267. JPEN J Parenter Enteral Nutr. 1998. PMID: 9527962 Clinical Trial.
-
[Elimination and metabolism of MCT-containing fat emulsions in postoperative patients in the framework of total parenteral nutrition].Infusionstherapie. 1990 Aug;17(4):185-90; 193-6. Infusionstherapie. 1990. PMID: 2120133 Review. German.
-
[Energy substrates in parenteral nutrition].Ann Fr Anesth Reanim. 1991;10(6):565-79. doi: 10.1016/s0750-7658(05)80296-5. Ann Fr Anesth Reanim. 1991. PMID: 1785708 Review. French.
Cited by
-
Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions.Intensive Care Med. 2010 May;36(5):735-49. doi: 10.1007/s00134-009-1744-5. Epub 2010 Jan 14. Intensive Care Med. 2010. PMID: 20072779 Free PMC article. Review.
-
n-3 fatty acids, inflammation, and immunity--relevance to postsurgical and critically ill patients.Lipids. 2004 Dec;39(12):1147-61. doi: 10.1007/s11745-004-1342-z. Lipids. 2004. PMID: 15736910 Free PMC article. Review.
-
Intralipid therapy and adverse reproductive outcome: is there any evidence?Reprod Fertil. 2021 Jun 3;2(3):173-186. doi: 10.1530/RAF-20-0052. eCollection 2021 Jul. Reprod Fertil. 2021. PMID: 35118388 Free PMC article.
-
Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications.Front Pharmacol. 2020 Apr 29;11:506. doi: 10.3389/fphar.2020.00506. eCollection 2020. Front Pharmacol. 2020. PMID: 32410990 Free PMC article. Review.
-
Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.Infect Immun. 2002 Nov;70(11):6471-4. doi: 10.1128/IAI.70.11.6471-6474.2002. Infect Immun. 2002. PMID: 12379731 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials